PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level. (2019)
Attributed to:
Understanding and Ameliorating Pathogenesis in FSHD
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddz043
PubMed Identifier: 31067297
Publication URI: http://europepmc.org/abstract/MED/31067297
Type: Journal Article/Review
Volume: 28
Parent Publication: Human molecular genetics
Issue: 13
ISSN: 0964-6906